Schedule / Program
Schedule
Coming soon
Program
Special Lecture
Special Lecture1
scheduleJune 17 Tue. 11:20 - 12:20, Venue A
From abiogenesis to ChatGPT: An emergence after 3.8 billion years.
Speaker
- Shinichi Nishikawa
- Professor Emeritus of Kyoto University
Special Lecture2
scheduleJune 18 Wed. 11:00 - 12:00, Venue A
Cancer stromal targeting (CAST) therapy
Speaker
- Yasuhiro Matsumura
- RIN Institute Inc. National Cancer Center Research Institute
Special Event
Coming soon
Presidential Lecture
Coming soon
Symposium
Symposium1
scheduleJune 17 Tue. 9:15 - 11:15, Venue A
AI, Computer Science, and Drug Discovery
Chairs
- Hiroshi Tsugawa
- Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science
- Masahito Ohue
- School of Computing, Institute of Science Tokyo
Speakers
Pattern Recognition of Chemical Structures and ADMET Prediction by Language AI
- Tadahaya Mizuno
- Graduate School of Pharmaceutical Sciences, The University of Tokyo
Laboratory automation for efficient drug discovery research
- Naruki Yoshikawa
- Division of Computational Drug Discovery and Design, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo
Data-Driven Approaches in Drug Discovery and Vaccine Development
- Yayoi Natsume-Kitatani
- Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition
Computational mass spectrometry to deepen the understanding of metabolite diversity
- Hiroshi Tsugawa
- Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science
AI-driven multimodality drug discovery
- Masahito Ohue
- School of Computing, Institute of Science Tokyo
Symposium2
scheduleJune 17 Tue. 9:15 - 11:15, Venue B
Chemical and material technologies driving next-generation DDS
Chair
- Nobuhiro Nishiyama
- Professor, Institute of Integrated Research, Institute of Science Tokyo
Speakers
Therapeutic In Vivo Synthetic Chemistry
- Katsunori Tanaka
- Department of Chemical Science and Engineering, Institute of Science Tokyo
Biofunctional Synthetic Chemistry laboratory, RIKEN Pioneering Research Institute
JigSAP -Sustained-Release Peptide Hydrogel - for the Treatment of Ischemic Stroke
- Itsuki Ajioka
- Center for Brain Integration Research (CBIR), Institute of Integrated Research (IIR), Institute of Science Tokyo
Nanomedicines for immunotherapy
- Horacio Cabral
- Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
Regulation of cellular phenotypes with disk-shaped polymer micro-patches and its application to solid tumor treatment including glioblastoma
- Tatsuya Fukuta
- Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University
Biomolecule Delivery Systems Based on Combination of Polyphenol and Precision Synthetic Polymers for Potential Application to Gene Therapy
- Yuto Honda
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology
Symposium3
scheduleJune 17 Tue. 9:15 - 11:15, Venue C
Advancements in Antibody–Drug Conjugates and Future Outlook for Next Generation ADCs
Chairs
- Shino Manabe
- Laboratory of Synthetic Biomolecular Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University
- Koji Abe
- Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.
Speakers
Deepening and Advancing ADC Technology
- Shino Manabe
- Laboratory of Synthetic Biomolecular Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University
Applications to Various Antibody Conjugates Using Antibody Site-Specific Conjugation Method AJICAP®
- Tomohiro Fujii
- Ajinomoto Co., INC
Research and development of antibody-drug conjugates (ADCs) loaded with a potent DNA topoisomerase I inhibitor
- Takashi Nakada
- Modality Research Laboratories I Research Function R&D Division, Daiichi Sankyo Co., Ltd.
Broad-spectrum efficacy of CEACAM6-targeted antibody–drug conjugate with BET protein degrader in solid tumor mouse models
- Hiroyuki Kogai
- Cell Lineage & Differentiation Domain, DHBL, Eisai Co. Ltd.
Advance of Cyclic Peptides in Radiopharmaceuticals and Beyond Using PeptiDream's Peptide Drug Platform System (PDPS) Technology
- Masato Murakami
- Chief Medical Officer of PeptiDream Inc.
President and Representative Director of PDRadiopharma Inc.
Vice President, Japan Radiopharmaceuticals Association (JRPA)
Symposium4
scheduleJune 17 Tue. 13:40 - 15:40, Venue B
The latest technologies of animal alternatives in DDS research
Chairs
- Yoshikatsu Koga
- Center for Promotion of Translational Research (CPOT), National Cancer Center
- Yamamoto Yoshiyuki
- Department of gastroenterology, University of Tsukuba
Speakers
Trends of the cosmetics industry's efforts for alternatives to animal experiments
- Akiko Tamura
- Brand Value R&D Institute, Shiseido Co., Ltd.
Animals and Alternatives to animal experiments - Expectations for the correlation including MPS
- Yuzuru Ito
- Faculty of Life and Environmental Sciences, University of Tsukuba
Advancement of MPS Research for Animal Alternatives in Pharmaceutical Industry
- Wataru Obuchi
- Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd.
Shaping the Future of Experimental Animals with Mice
- Aya Uchida
- The Jackson Laboratory Japan, Technical Information Services
Standardization of alternatives to animal testing and the role of JaCVAM
- Takao Ashikaga
- National Institute of Health Sciences, Division of Genome Safety Science
Symposium5
scheduleJune 17 Tue. 13:40 - 15:40, Venue C
Development of next-generation vaccines and DDS
Chairs
- Makiya Nishikawa
- Faculty of Pharmaceutical Sciences, Tokyo University of Science
- Fuminori Sakurai
- Faculty of Pharmacy, Kindai University
Speakers
Development of next-generation vaccines and DDS - What is the role of DDS researchers in the development of next-generation vaccines ? -
- Fuminori Sakurai
- Faculty of Pharmacy, Kindai University
Next-generation vaccine against novel coronaviruses
- Daisuke Muraoka
- Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute
Next-generation vaccine development based on DDS for nucleic acid adjuvants and antigens
- Makiya Nishikawa
- Faculty of Pharmaceutical Sciences, Tokyo University of Science
Utilization of Bacterium-like Particles for Vaccine Antigen Delivery
- Keita Takahashi
- Gifu Pharmaceutical University, Laboratory of Microbiology and Immunology
Research and Development of mRNA Vaccine “Daichirona”
- Toshihiro Kiho
- Daiichi-Sankyo R&D Division Vaccine Research Laboratories
Development of Anti-senescence Therapy Targeting Seno-Anergy
- Tohru Minamino
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine
Symposium6
scheduleJune 18 Wed. 8:55 - 10:55, Venue B
Diverse nucleic acid modalities open up new therapeutic strategies
Chairs
- Kanjiro Miyata
- Graduate School of Engineering, The University of Tokyo
- Takashi Nakamura
- Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
Speakers
Development trends and future prospects for nucleic acid-based modalities
- Takao Inoue
- National Institute of Health Sciences
Anticancer effects of nucleic acid aggregates
- Akimitsu Okamoto
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo
Nucleic acid adjuvant system-based cancer immunotherapy
- Takashi Nakamura
- Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
Development of anti-cancer siRNA therapeutics targeting the transcription factor PRDM14, a molecule responsible for cancer stem cell properties.
- Hiroaki Taniguchi
- Division of Innovative Cancer Control Research, Cancer Research Institute of Kanazawa University
Development of mRNA vaccines and therapeutics against infectious diseases and our efforts toward future clinical translation
- Satoshi Uchida
- Department of Advanced Nanomedical Engineering, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo
Symposium7
scheduleJune 18 Wed. 8:55 - 10:55, Venue C
New frontiers in radiopharmaceutical development and theranostics
Chairs
- Tadashi Watabe
- Graduate School of Medicine, The University of Osaka
- Hiroki Takashima
- Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Speakers
Drug Delivery System in radioimmunotherapy with astatine-211
- Hiroki Takashima
- Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Development of Radioisotope Labeling Techniques and Their Application to Radiotheranostic Probes
- Hiroyuki Kimura
- Agency for Health, Safety and Environment, Kyoto University
Development of radiotheranostic antibody drug for pancreatic cancer and its basic research
- Naoaki Yamada
- Research Center, Nihon Medi-Physics Co. Ltd.
Preclinical evaluation of Cadherin 3 (CDH3) -targeted alpha particle emitting radiopharmaceutical therapy, 225Ac-PPMX-T002 for the treatment of solid cancer
- Shinji Hagiwara
- Research and Development Division, Perseus Proteomics Inc.
Targeted alpha therapy using astatine: from preclinical to clinical applications
- Tadashi Watabe
- Graduate School of Medicine, The University of Osaka
Symposium8
scheduleJune 18 Wed. 15:15 - 17:15, Venue B
Chemical Biology Pioneering New Frontiers of Drug Delivery Systems
Chairs
- Kenjiro Hanaoka
- Graduate School of Pharmaceutical Sciences, Keio University
- Yosuke Demizu
- Division of Organic Chemistry, National Institute of Health Sciences
Speakers
Development of a near-infrared (NIR) dye for photoimmunotherapy and its application
- Kenjiro Hanaoka
- Graduate School of Pharmaceutical Sciences, Keio University
Exosome Hijacking DDS and Light-Triggered Genome Editing
- Asako Yamayoshi
- Department of Life Science and Technology, Institute of Science Tokyo
Polymer design for enhanced drug delivery
- Kanjiro Miyata
- Graduate School of Engineering, The University of Tokyo
Molecular targeted chemogenetics: cell-type-specific control of cell-surface receptors in vivo
- Shigeki Kiyonaka
- Graduate School of Engineering, Nagoya University
Development and Application of DDS Carrier Peptides
- Yosuke Demizu
- Division of Organic Chemistry, National Institute of Health Sciences
Symposium9
scheduleJune 18 Wed. 15:15 - 17:15, Venue C
Frontiers in antibody engineering for DDS
Chairs
- Ryutaro Asano
- Dept. of Biotech. & Life Sci., Grad. Sch. of Eng., Tokyo Univ. of Agric. & Tech.
- Masahiro Tatsuno
- Clinical Pharmacology Deupty Head, Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd.
Speakers
Prodrugation of bispecific antibodies leading to cancer-specific functionalization
- Ryutaro Asano
- Dept. of Biotech. & Life Sci., Grad. Sch. of Eng., Tokyo Univ. of Agric. & Tech.
Granting BBB-penetrating ability to antibody drugs using LassoGraft technology
- Junichi Takagi
- Institute for Protein Research, The University of Osaka
Development of antibody-drug conjugates using AccumBody, tissue-specific delivering antibody
- Yuji Ito
- Department of Science, Graduate School of Science and Engineering, Kagoshima University
Catalytic antibody (Antigenase) directly damaging cancer cell
- Emi Hifumi
- Institute for Research Management, Oita University
Novel antibody engineering technologies enabling subcutaneous anti-complement C5 antibody therapy
- Kenta Haraya
- Research Division, Discovery Biologics Department, Chugai Pharmaceutical Co., Ltd.
Clinical development of Crovalimab dosage optimization - beyond the drug-target-drug complex -
- Tomohisa Saito
- Chugai Pharmaceutical. Co., Ltd. Pharmaceutical Science department
Oral Presentations
Coming soon
Poster Presentations
Coming soon
Luncheon Seminar
Coming soon
General Meeting
Coming soon
Award Ceremony / Award Lecture
Coming soon
Corporate Exhibition Presentations
Coming soon